The co-inhibitory receptor TIGIT promotes tissue-protective functions in T cells.

Saved in:
Bibliographic Details
Title: The co-inhibitory receptor TIGIT promotes tissue-protective functions in T cells.
Authors: Panetti C; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland., Daetwyler R; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland., Moncsek A; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland., Patikas N; The Gene Lay Institute of Immunology and Inflammation of Brigham and Women's Hospital, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA., Agrafiotis A; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; Institute of Microbiology, ETH Zurich, Zurich, Switzerland., Tang A; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.; La Trobe University, Bundoora, Victoria, Australia., Andreata F; Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Fumagalli V; Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., De Lima J; Department of Biomedicine, University of Basel, Basel, Switzerland., Wen L; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia., King CG; Department of Biomedicine, University of Basel, Basel, Switzerland., Vasanthakumar A; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.; La Trobe University, Bundoora, Victoria, Australia.; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Iannacone M; Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Kallies A; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.; Institute of Molecular Medicine & Experimental Immunology, University Hospital Bonn, Bonn, Germany., Yermanos A; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Botnar Institute of Immune Engineering, Basel, Switzerland., Hemberg M; The Gene Lay Institute of Immunology and Inflammation of Brigham and Women's Hospital, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA., Joller N; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland. nicole.joller@uzh.ch.; Center for Human Immunology, University of Zurich, Zurich, Switzerland. nicole.joller@uzh.ch.
Source: Nature immunology [Nat Immunol] 2025 Nov; Vol. 26 (11), pp. 2074-2085. Date of Electronic Publication: 2025 Oct 15.
Publication Type: Journal Article
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-2916
DOI:10.1038/s41590-025-02300-w